American Flag

Valuation

Financial Asset and Business Valuation

Financial Asset and Business Valuation

NERA economists help clients establish a fair and accurate valuation of a business and/or IPO. Business valuation depends on financial forecasting and analysis -- but that is only the beginning. To make sound forecasts, it is important to understand the dynamics of the marketplace. This is the hallmark of NERA's approach -- one that has been successfully used by business owners and attorneys in litigation, and investment bankers/venture capitalists interested in acquiring a real measure of business value.

Name Title Location Phone Email
Oscar Arnedillo Managing Director Madrid +34 91 521 0020 oscar.arnedillo@nera.com
Dr. Fabrizio Hernández Managing Director Madrid
Milan 		+34 91 521 00 20
+39 02 30577800 		fabrizio.hernandez@nera.com
Bradley A. Heys Managing Director Toronto
New York City 		+1 416 868 7312
+1 212 345 3000 		brad.heys@nera.com
Dr. Vinita Juneja Managing Director
Chair of NERA's White Collar, Investigations and Enforcement Practice 		New York City
London
Toronto 		+1 212 345 3148
+44 20 7659 8618
+1 416 868 7314 		vinita.juneja@nera.com
Dr. Jeff D. Makholm Managing Director Boston +1 617 927 4540 jeff.makholm@nera.com
Dr. Denise Neumann Martin Managing Director Miami +1 305 808 7880 denise.martin@nera.com
Dr. Faten Sabry Managing Director
Chair of NERA's Global Securities and Finance Practice
Bankruptcy Practice Chair 		New York City
London 		+1 212 345 3285
+44 20 7659 8618 		faten.sabry@nera.com
Kurt G. Strunk Managing Director New York City +1 212 345 5035 kurt.strunk@nera.com
Dr. Ling Ling Ang Director Washington, DC
Chicago 		+1 202 466 9259
+312 573 2827 		lingling.ang@nera.com
Dr. Airat Chanyshev Associate Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Bryan Ray Associate Director White Plains, NY +1 914 448 4004 bryan.ray@nera.com
Dr. Michael Baye Affiliated Academic Washington, DC +1 202 466 9298 michael.baye.affiliate@nera.com
Mark L. Berenblut Affiliated Consultant Toronto
New York City
London 		+1 416 868 7311
+1 917 475 0020
+44 20 3769 1096 		mark.berenblut.affiliate@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London 		+1 212 345 5407
+44 20 7659 8500 		andrew.carron.affiliate@nera.com
Dr. Alan Cox Affiliated Consultant San Francisco +1 415 291 1000 alan.cox.affiliate@nera.com
Dr. Thomas McCarthy Affiliated Consultant Los Angeles +1 213 346 3000 thomas.mccarthy.affiliate@nera.com
Todd Morrison Affiliated Consultant Washington, DC +1 202 466 9213 todd.morrison.affiliate@nera.com
Dr. Michael Rosenzweig Affiliated Consultant Washington, DC +1 202 466 9231 michael.rosenzweig.affiliate@nera.com
Title Type Author
How Will the LIBOR Transition Affect Mortgage Consumers? White Paper Dr. Faten Sabry, Dr. Ignacio Franceschelli, and Ramisa Roya
Trends in Canadian Securities Class Actions: 2021 Update White Paper Bradley A. Heys, Robert Patton, Jielei Mao
Transfer Pricing Solutions for Intragroup Shared Services White Paper Dr. Niraja Srinivasan, et al.
‘Coca-Cola’ vs. Section 482: Is It Time to Refresh the Regulatory Guidance? Published Article Dr. Harlow Higinbotham and Dr. Niraja Srinivasan
Snapshot of Recent Trends in Asbestos Litigation 2021 Update Mary Elizabeth C. Stern and Lucy P. Allen
Going digital multinationals: Navigating economic and social imperatives in a post-pa... Published Article Dr. Niraja Srinivasan, et al.
NERA Experts Contribute Chapter to "The Future of the Profit Split Method" Book Dr. Harlow Higginbotham and Dr. Vladimir Starkov
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Transfer Pricing Roundtable in Financier Worldwide. Expert QA Dr. Vladimir Starkov and Philip de Homont
Amount B: Facts and Circumstances Matter—Even for Routine Distributors Published Article Dr. Harlow Higinbotham, Dr. Niraja Srinivasan, and Dr. Vladimir Starkov